CIK 0001178670
- Large accelerated filer
ALNYLAM PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- ALNY
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 770602661
- Phone
- +1 617-551-8200
- Business address
- 675 WEST KENDALL STREET, HENRI A. TERMEER SQUARE, CAMBRIDGE, MA, 02142
- Former names
- ALNYLAM PHARMACEUTICALS INC
- Open-market buys, last 90 days
- $543,126
- in 2 filings
- Open-market sales, last 90 days
- $398,855
- in 1 filing
Net +$144,271. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-05-20 | MARAGANORE JOHN Chief Executive Officer | Sale | −5,013 | $144.33 | $724K | 197,589 |
| 2020-05-20 | MARAGANORE JOHN Chief Executive Officer | Exercise or conversion · Stock Option (right to buy) | −34,765 | 69,530 | ||
| 2020-05-06 | Greenstreet Yvonne Chief Operating Officer | Exercise or conversion | +50,000 | $77.10 | $3.9M | 54,820 |
| 2020-05-06 | Greenstreet Yvonne Chief Operating Officer | Sale | −50,000 | $150.00 | $7.5M | 4,820 |
| 2020-05-06 | Greenstreet Yvonne Chief Operating Officer | Exercise or conversion · Stock Option (right to buy) | −50,000 | 75,000 | ||
| 2020-05-05 | Greenstreet Yvonne Chief Operating Officer | Exercise or conversion | +6,250 | $42.22 | $264K | 11,070 |
| 2020-05-05 | Greenstreet Yvonne Chief Operating Officer | Exercise or conversion | +1,561 | $42.22 | $66K | 12,631 |
| 2020-05-05 | Greenstreet Yvonne Chief Operating Officer | Sale | −7,811 | $140.00 | $1.1M | 4,820 |
| 2020-05-05 | Greenstreet Yvonne Chief Operating Officer | Exercise or conversion · Performance Stock Option 2016 (right to buy) | −6,250 | 650 | ||
| 2020-05-05 | Greenstreet Yvonne Chief Operating Officer | Exercise or conversion · Stock Option (right to buy) | −1,561 | 14,064 | ||
| 2020-04-20 | KEATING LAURIE EVP, Chief Legal Officer | Exercise or conversion | +10,000 | $77.40 | $774K | 24,492 |
| 2020-04-20 | KEATING LAURIE EVP, Chief Legal Officer | Sale | −10,000 | $139.00 | $1.4M | 14,492 |
| 2020-04-20 | KEATING LAURIE EVP, Chief Legal Officer | Exercise or conversion · Stock Option (right to buy) | −10,000 | 42,000 | ||
| 2020-04-20 | Vaishnaw Akshay President, R&D | Exercise or conversion | +21,000 | $42.22 | $887K | 35,119 |
| 2020-04-20 | Vaishnaw Akshay President, R&D | Exercise or conversion | +971 | $42.22 | $41K | 36,090 |
| 2020-04-20 | Vaishnaw Akshay President, R&D | Sale | −21,971 | $140.00 | $3.1M | 14,119 |
| 2020-04-20 | Vaishnaw Akshay President, R&D | Exercise or conversion · Performance Stock Option 2016 (right to buy) | −21,000 | 0 | ||
| 2020-04-20 | Vaishnaw Akshay President, R&D | Exercise or conversion · Stock Option (right to buy) | −971 | 5,279 | ||
| 2020-04-07 | Greene Barry E President | Grant or award | +5,417 | 63,899 | ||
| 2020-04-07 | Greene Barry E President | Shares withheld for taxes | −1,599 | $104.75 | $167K | 62,300 |
Page 77 of 80 · 1,590 trades